Harpoon Therapeutics, Inc.·4

Dec 26, 4:10 PM ET

Bucher James B 4

4 · Harpoon Therapeutics, Inc. · Filed Dec 26, 2023

Insider Transaction Report

Form 4
Period: 2023-12-21
Bucher James B
Chief Legal Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-12-21+110,000110,000 total
    Exercise: $11.30Exp: 2033-12-20Common Stock (110,000 underlying)
Footnotes (1)
  • [F1]25% of the total number of shares subject to the stock option shall vest and become exercisable on the first anniversary of December 21, 2023, and the remainder vests in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4